4.7 Article

Consensus on current management of endometriosis

Journal

HUMAN REPRODUCTION
Volume 28, Issue 6, Pages 1552-1568

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humrep/det050

Keywords

endometriosis; evidence based; management; WES Montpellier Consortium; World Endometriosis Society

Funding

  1. EMD Merck Serono
  2. IBSA
  3. LabCorp
  4. Schering Plough
  5. Auxogyn
  6. Bayer Pharma AG
  7. MSD Netherlands BV
  8. Ferring Netherlands BV
  9. Ferring Pharmaceuticals
  10. Genevrier
  11. Covidien
  12. Femasys
  13. Olympus
  14. Novartis
  15. Novartis, Abbott
  16. Merck-Serono
  17. MSD
  18. Medical Research Council [MR/K011480/1, G0601458] Funding Source: researchfish
  19. MRC [MR/K011480/1, G0601458] Funding Source: UKRI

Ask authors/readers for more resources

Is there a global consensus on the management of endometriosis that considers the views of women with endometriosis? It was possible to produce an international consensus statement on the current management of endometriosis through engagement of representatives of national and international, medical and non-medical societies with an interest in endometriosis. Management of endometriosis anywhere in the world has been based partially on evidence-based practices and partially on unsubstantiated therapies and approaches. Several guidelines have been developed by a number of national and international bodies, yet areas of controversy and uncertainty remain, not least due to a paucity of firm evidence. A consensus meeting, in conjunction with a pre- and post-meeting process, was undertaken. A consensus meeting was held on 8 September 2011, in conjunction with the 11th World Congress on Endometriosis in Montpellier, France. A rigorous pre- and post-meeting process, involving 56 representatives of 34 national and international, medical and non-medical organizations from a range of disciplines, led to this consensus statement. A total of 69 consensus statements were developed. Seven statements had unanimous consensus; however, none of the statements were made without expression of a caveat about the strength of the statement or the statement itself. Only two statements failed to achieve majority consensus. The statements covered global considerations, the role of endometriosis organizations, support groups, centres or networks of expertise, the impact of endometriosis throughout a womans life course, and a full range of treatment options for pain, infertility and other symptoms related to endometriosis. This consensus process differed from that of formal guideline development. A different group of international experts from those participating in this process would likely have yielded subtly different consensus statements. This is the first time that a large, global, consortium, representing 34 major stake-holding organizations from five continents, has convened to systematically evaluate the best available current evidence on the management of endometriosis, and to reach consensus. In addition to 18 international medical organizations, representatives from 16 national endometriosis organizations were involved, including lay support groups, thus generating input from women who suffer from endometriosis. The World Endometriosis Society commissioned and hosted the consensus meeting. Financial support for participants to attend the meeting was provided by the organizations that they represented. There was no other specific funding for this consensus process. Full disclosures of all participants are presented herein.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available